RESET-HCM
2017
Randomised Exploratory Study of Exercise Training in Hypertrophic Cardiomyopathy
In 136 adults with hypertrophic cardiomyopathy, 16 weeks of moderate-intensity aerobic exercise training produced a small increase in peak oxygen consumption, with no ventricular arrhythmias, compared with usual activity.
Result
Primary endpoint: Change in peak oxygen consumption at 16 weeks
Between-group difference 1.27 mL/kg/min (95 % CI 0.17–2.37; p=0.02). No sustained ventricular arrhythmia, cardiac arrest, appropriate defibrillator shock or death in either group.
- Subtopic
- Exercise in cardiomyopathy
- Design
- Randomised clinical trial over 16 weeks
- Relevance
- Supporting: context rather than must-know.
- Source
- Saberi S, Wheeler M, Bragg-Gresham J, et al. JAMA. 2017;317(13):1349-1357.doi 10.1001/jama.2017.2503
Discussion & critique
Underpowered for safety by design: 136 patients over 16 weeks can only crudely exclude an arrhythmic hazard, and the gain in peak oxygen uptake is of borderline clinical importance. It is the sole randomised evidence in hypertrophic cardiomyopathy and overturned decades of blanket exercise restriction.